Recent publications by Researchers affiliated with the Centre for Tropical Medicine and Global Health
Detection and significance of neuronal autoantibodies in patients with meningoencephalitis in Vientiane, Lao PDR.
Uy CE. et al, (2022), Transactions of the Royal Society of Tropical Medicine and Hygiene
A case-control study of the causes of acute respiratory infection among hospitalized patients in Northeastern Laos.
Phommasone K. et al, (2022), Scientific reports, 12
Genetic diversity of Leptospira isolates in Lao PDR and genome analysis of an outbreak strain
Grillová L. et al, (2021), PLOS Neglected Tropical Diseases, 15, e0010076 - e0010076
Clustering of malaria in households in the Greater Mekong Subregion: operational implications for reactive case detection
Mukaka M. et al, (2021), Malaria Journal, 20
A spatio-temporal analysis of scrub typhus and murine typhus in Laos; implications from changing landscapes and climate
Roberts T. et al, (2021), PLOS Neglected Tropical Diseases, 15, e0009685 - e0009685
Development of Weight and Age-based Dosing of Daily Primaquine for Radical Cure of Vivax Malaria
Taylor WR. et al, (2021)
Defining the burden of febrile illness in rural South and Southeast Asia: an open letter to announce the launch of the Rural Febrile Illness project
Chandna A. et al, (2021), Wellcome Open Research, 6, 64 - 64
Outcome of Japanese Encephalitis Virus (JEV) Infection in Pediatric and Adult Patients at Mahosot Hospital, Vientiane, Lao PDR.
Mayxay M. et al, (2020), The American journal of tropical medicine and hygiene, 104, 567 - 575
Diagnostic accuracy of an in-house Scrub Typhus enzyme linked immunoassay for the detection of IgM and IgG antibodies in Laos
Elders PND. et al, (2020), PLOS Neglected Tropical Diseases, 14, e0008858 - e0008858
Correction to: The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
Phommasone K. et al, (2020), Malaria Journal, 19
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Imwong M. et al, (2020), The Lancet Infectious Diseases, 20, 1470 - 1480
The use of ultrasensitive quantitative-PCR to assess the impact of primaquine on asymptomatic relapse of Plasmodium vivax infections: a randomized, controlled trial in Lao PDR
Phommasone K. et al, (2020), Malaria Journal, 19
Association between the proportion of Plasmodium falciparum and Plasmodium vivax infections detected by passive surveillance and the magnitude of the asymptomatic reservoir in the community: a pooled analysis of paired health facility and community data
Stresman G. et al, (2020), The Lancet Infectious Diseases, 20, 953 - 963
Typhoid in Laos: An 18-Year Perspective.
Roberts T. et al, (2020), The American journal of tropical medicine and hygiene, 102
Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials
Phommasone K. et al, (2020), PLOS ONE, 15, e0228190 - e0228190
Intracluster correlation coefficients in the Greater Mekong Subregion for sample size calculations of cluster randomized malaria trials
Peerawaranun P. et al, (2019), Malaria Journal, 18
Molecular characterization and mapping of glucose-6-phosphate dehydrogenase (G6PD) mutations in the Greater Mekong Subregion
Bancone G. et al, (2019), Malaria Journal, 18
The probability of a sequential Plasmodium vivax infection following asymptomatic Plasmodium falciparum and P. vivax infections in Myanmar, Vietnam, Cambodia, and Laos
von Seidlein L. et al, (2019), Malaria Journal, 18
Management of Central Nervous System Infections, Vientiane, Laos, 2003–2011
Dubot-Pérès A. et al, (2019), Emerging Infectious Diseases, 25, 898 - 910
Treatment-seeking behaviour for febrile illnesses and its implications for malaria control and elimination in Savannakhet Province, Lao PDR (Laos): a mixed method study.
Adhikari B. et al, (2019), BMC health services research, 19